Article info
PDFBrief reports
Ethical and economic considerations of rare diseases in ethnic minorities: the case of mucopolysaccharidosis VI in Colombia
- Correspondence to Dr Diego Rosselli, Clinical Epidemiology and Biostatistics, Pontificia Universidad Javeriana, Carrera 7 No 40-62, Bogota 110311, Colombia; diego.rosselli{at}gmail.com
Citation
Ethical and economic considerations of rare diseases in ethnic minorities: the case of mucopolysaccharidosis VI in Colombia
Publication history
- Received August 25, 2011
- Revised February 8, 2012
- Accepted April 5, 2012
- First published May 1, 2012.
Online issue publication
October 29, 2012
Article Versions
- Previous version (1 May 2012).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions This is an open-access article distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits use, distribution, and reproduction in any medium, provided the original work is properly cited, the use is non commercial and is otherwise in compliance with the license. See: http://creativecommons.org/licenses/by-nc/2.0/ and http://creativecommons.org/licenses/by-nc/2.0/legalcode.
Other content recommended for you
- Diagnosis and management of ophthalmological features in patients with mucopolysaccharidosis
- Cardiac issues in adults with the mucopolysaccharidoses: current knowledge and emerging needs
- Progression of eye disease over 15 years in a patient with mucopolysaccharidosis type VI on enzyme replacement therapy
- Screening patients referred to a metabolic clinic for lysosomal storage disorders
- Musculoskeletal manifestations of lysosomal storage disorders
- Bio-Plex immunoassay measuring the quantity of lysosomal N-acetylgalactosamine-6-sulfatase protein in dried blood spots for the screening of mucopolysaccharidosis IVA in newborn: a pilot study
- ‘Doctor Google’ ending the diagnostic odyssey in lysosomal storage disorders: parents using internet search engines as an efficient diagnostic strategy in rare diseases
- Clinical and morphological features including expression of βig-h3 and keratan sulphate proteoglycans in Maroteaux-Lamy syndrome type B and in normal cornea
- Clinical course of sly syndrome (mucopolysaccharidosis type VII)
- Avoiding diagnostic delay for mucopolysaccharidosis IIIB: do not overlook common clues such as wheezing and otitis media